WaveLight® EX500 Excimer Laser System for the Correction of Myopia Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap
Public ClinicalTrials.gov record NCT04219891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pivotal Trial of WaveLight® EX500 Excimer Laser System for the Correction of Myopia With and Without Astigmatism Using InnovEyes™ in Conjunction With InnovEyes™ Sightmap
Study identification
- NCT ID
- NCT04219891
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Alcon Research
- Industry
- Enrollment
- 272 participants
Conditions and interventions
Conditions
Interventions
- WaveLight EX500 excimer laser system with InnovEyes sightmap Device
- LASIK Procedure
- InnovEyes sightmap Device
Device · Procedure
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 8, 2020
- Primary completion
- Nov 8, 2022
- Completion
- Nov 8, 2022
- Last update posted
- Apr 5, 2025
2020 – 2022
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcon Investigative Site | San Diego | California | 92122 | — |
| Price Vision Group | Indianapolis | Indiana | 46260 | — |
| Alcon Investigative Site | Chevy Chase | Maryland | 20815-7018 | — |
| Alcon Investigative Site | Kansas City | Missouri | 64154 | — |
| Alcon Investigative Site | St Louis | Missouri | 63017 | — |
| Alcon Investigative Site | Omaha | Nebraska | 68135 | — |
| Alcon Investigative Site | Mt. Pleasant | South Carolina | 29464 | — |
| Alcon Investigative Site | Sioux Falls | South Dakota | 57108 | — |
| Alcon Investigative Site | Dallas | Texas | 75243 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04219891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 5, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04219891 live on ClinicalTrials.gov.